Similarly, in the GEO dataset GSE18728, breast cancer patients who received neoadjuvant chemotherapy and classified as non-responders [24] displayed marginally higher SPIN1 expression than those classified as responders (Fig. 1h, P = 0.0655). This evidence concerns the gene SPIN1 and breast carcinoma.